AWARDPURCHASE ORDERSmall business
Purchase order 75N92023P00014FUNCTIONAL FLUIDICS INC.
Overview
Award facts
- Net obligations
- $100K
- $100,000of $100K potential value
- Outlays (paid to date)
- $100K
- $100K paid of $100K obligated$100,000
- Period of performance
- Nov 21, 2022 to Nov 20, 2024
- Ended
- Modifications
- 0
- Latest action Nov 21, 2022
- Contract type
- Purchase order
- PIID 75N92023P00014
Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.
Description of requirement
RBC HEALTH AS A NOVEL BIOMARKER OF A SUCCESSFUL OUTCOME IN HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR SICKLE CELL DISEASE (SCD)
Dates and value
- Award date
- Signed on Nov 21, 2022
- Potential end of performance
- Nov 19, 2024
- Current value
- $100,000Base and exercised options
- Potential value (if all options are exercised)
- $100,000
Obligations by fiscal year of action
- FY2023: $100,000
Total across 1 fiscal year: $100,000
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Nov 21, 2022. View on USAspending · Recipient on SAM.gov
Recipient
LocationDETROIT, MI
UEIEDDMU2KMYPE3
CAGE code77VZ4
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyFUNCTIONAL FLUIDICS INC.
Business types and certifications
Minority-ownedFor-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NHLBI
- Funded from
- National heart, lung, and blood institute (0872)Program activities075-0872Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Detroit, Wayne County, Michigan 48202-3474
- Congressional district (place of performance)
- MI-13As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- Q301MEDICAL- LABORATORY TESTING (service)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75N92023Q0540
- Solicitation date
- Oct 27, 2022
- Notices
- Presolicitation posted Oct 27, 2022
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Rbc health as a novel biomarker of a successful outcome in hematopoietic stem cell transplantation (
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Nov 21, 2022Base obligation at award: $100,000
- Latest action
- Nov 21, 2022 — Base awardModification 0; obligation change +$100,000
- Actions by type
- Base award1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
- Latest action: change in base and exercised options
- $100,000
- Latest action: change in base and all options
- $100,000
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N920
- Transactions recorded under this award key
- 1
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N920
- Treasury accounts
- 075-2023/2023-0872-000
- Object classes
- 25.6: Medical care
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression